ARTICLE | Company News
Shape Pharmaceuticals, TetraLogic deal
April 14, 2014 7:00 AM UTC
Oncology and infectious diseases company TetraLogic will acquire Shape for $13 million up front in cash, plus undisclosed milestones and tiered royalties. TetraLogic will gain Shape's suberohydroxamic...